Improving Adherence to Adjuvant Hormonal Therapy Among Disadvantaged Women Diagnosed with Breast Cancer in South Carolina: Proposal for a Multimethod Study

BACKGROUND: Current clinical guidelines recommend that hormone receptor–positive breast cancer survivors take adjuvant hormonal therapy (AHT) for 5 to 10 years, following the end of definitive treatment. However, fewer than half of patients adhere to the guidelines, and suboptimal adherence to AHT i...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:JMIR Res Protoc
Main Authors: Felder, Tisha M, Heiney, Sue P, Hebert, James R, Friedman, Daniela B, Elk, Ronit, Franco, Regina, Gansauer, Lucy, Christensen, Barbara, Ford, Marvella E
Formato: Artigo
Idioma:Inglês
Publicado: JMIR Publications 2020
Assuntos:
Proposal
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7499167/
https://ncbi.nlm.nih.gov/pubmed/32880374
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2196/17742
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares